This series of free public talks reviews the current state of research on the general topic of marijuana for medical purposes, provides space for an informed discussion on the legal aspects of marijuana use and provides perspectives from the licensed production, genetics, pharmaceutical utility, medical profession, and human behavioural aspects of marijuana.
Dr. Francesca Filbey received a PhD in Experimental Neuropsychology from the Institute of Psychiatry, King's College London and postdoctoral fellowship in Human Neuroimaging at the National Institute of Mental Health, NIH. Dr. Filbey is currently an Associate Professor of Cognitive Neuroscience and Director of Cognitive Neuroscience Research of Addictive Disorders at the Center of Brain Health, School of Behavioural and Brain Sciences at the University of Texas at Dallas, and Adjunct Associate Professor at the University of Texas Southwestern Medical School, Department of Psychiatry. She also holds the Endowed Bert Moore Chair of Behavioural and Brain Science. Dr. Filbey has received continued federal and non-federal funding over the last 15 years with over 60 peer-reviewed publications, several book chapters and an edited book. She is on the Editorial Board for the American Journal of Drug and Alcohol Abuse, Psychology of Addictive Behaviours, a Review Editor for several scientific journals. She is an active grant reviewer for several national and international funding agencies including chartered membership in the NIH Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section. She is also a voted Associate Member of the American College of Neuropsychopharmacology and a Member of the College on Problems of Drug Dependence.
The overarching goal of Dr. Filbey's research is to advance the understanding of biobehavioural mechanisms of addictive disorders towards the improvement of early detection and intervention. Her lab utilizes multimodal tools including MRI, EEG, fNIRS, rTMS and GWAs to examine cue-elicited craving, stress, and response inhibition across populations of substance abusers, binge eaters and risk-taking youth and adults.
Dr. Filbey's studies incorporate translational approaches from the fields of cognitive neuroscience, neuroimaging, genetics, neuropharmacology, psychology and psychiatry. Specifically, taking advantage of technological advancements, Dr. Filbey combines genomic and neuroimaging approaches to determine neurobiological markers for addiction. These projects move beyond simple classifications of presence or absence of a disorder by applying a deep phenotyping approach that consists of continuous variables from cognitive assessments in addition to biological processes. To that end, Dr. Filbey utilizes a stepwise approach that (1) defines the neural mechanisms that underlie behavioural symptoms of addictive disorders, then (2) determines the individual variability (genetic and environmental factors) that modulate these mechanisms, placing one at risk for these disorders. As a whole, these projects aim to advance understanding of biobehavioural mechanisms of addictive disorders.